Korea University Guro Hospital
Seoul, South Korea
NCT Number: NCT07099105
The goal of this observational study is compared the perioperative outcomes of robotic lobectomy using the SP system via the subcostal approach with those of multi-port robotic lobectomy using the Xi system via the intercostal approach.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Seoul, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Postoperatively day 0,1,2,3
Postoperative pain using visual analog scale (minimum =0, maximum=10), A lower value reflects a lesser degree of pain perception (lower scores mean a better outcome)
Time frame: Perioperative
Chest tube duration refers to the number of days a thoracic drain remains in situ following pulmonary surgery. The duration is measured in days (minimum: 1, maximum: no defined). Lower scores indicate a better outcome.
Korea University Guro Hospital
Other
Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer: A Single-centre Retrospective Propensity Matched Study
Acronym: SP vs MP robot
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06228508
Bronchial Neoplasms, Carcinoma, Bronchogenic
Paris, France
View Trial DetailsNCT04769388
Bronchial Neoplasms, Carcinoma, Bronchogenic
Beijing, China
View Trial DetailsNCT04348149
Bronchial Neoplasms, Carcinoma, Bronchogenic
Yangsan, Gyeongsangnam-do, South Korea
View Trial DetailsNCT05375994
Advanced Cancer, Bronchial Neoplasms
San Francisco, California, United States
View Trial Details